Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Irinotecan”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00215982
What this trial is testing

Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
H. Lee Moffitt Cancer Center and Research Institute 24
Testing effectiveness (Phase 2)Study completedNCT00004924
What this trial is testing

Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Yale University 28
Testing effectiveness (Phase 2)Ended earlyNCT00506168
What this trial is testing

Study of Irinotecan & Capecitabine in Metastatic Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsSecondaryDrug Therapy, Combination
National Cancer Center, Korea 37
Testing effectiveness (Phase 2)Ended earlyNCT01609231
What this trial is testing

A Trial of Dalotuzumab in Combination With Irinotecan Versus Cetuximab and Irinotecan for Participants With Metastatic Rectal Cancers (mRC) (MK-0646-025)

Who this might be right for
Rectal Neoplasms
Merck Sharp & Dohme LLC 11
Testing effectiveness (Phase 2)Study completedNCT01480986
What this trial is testing

IPO-NEC Trial:Study on the Efficacy and Safety Using Sequential IP Therapy and Oct Lar in the Treatment of Advanced GI NEC

Who this might be right for
Progression Free Survival of the Treatment
Peking University 40
Not applicableLooking for participantsNCT07340151
What this trial is testing

Resection/Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Adenocarcinoma of the Pancreas
The University of Texas Health Science Center at San Antonio 40
Early research (Phase 1)Study completedNCT00346801
What this trial is testing

CPT-11/Cisplatin and Celecoxib With Radiation Therapy for Patients With Unresectable Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 20
Large-scale testing (Phase 3)Study completedNCT00313872
What this trial is testing

Phase III Trial of DP Followed by FOLFIRI or the Reverse Sequence in Unresectable Gastric Cancer

Who this might be right for
Gastric CancerMetastases
Samsung Medical Center 200
Testing effectiveness (Phase 2)Study completedNCT00033657
What this trial is testing

Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Eastern Cooperative Oncology Group 97
Large-scale testing (Phase 3)Study completedNCT00068692
What this trial is testing

Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer

Who this might be right for
Rectal Mucinous AdenocarcinomaRectal Signet Ring Cell AdenocarcinomaRecurrent Rectal Carcinoma+8 more
National Cancer Institute (NCI) 225
Early research (Phase 1)Study completedNCT00215501
What this trial is testing

Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies

Who this might be right for
Solid Tumor
Dana-Farber Cancer Institute 54
Large-scale testing (Phase 3)Ended earlyNCT01014767
What this trial is testing

Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors

Who this might be right for
Brain CancerChoroid Plexus Tumors
Tufts Medical Center 27
Large-scale testing (Phase 3)Study completedNCT00374036
What this trial is testing

Metastatic Gastric Cancer FFCD 03-07

Who this might be right for
Stomach CancerNeoplasm Metastasis
University Hospital, Toulouse 416
Testing effectiveness (Phase 2)Looking for participantsNCT04901702
What this trial is testing

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

Who this might be right for
Recurrent Solid TumorRecurrent Ewing SarcomaRecurrent Hepatoblastoma+19 more
St. Jude Children's Research Hospital 90
Testing effectiveness (Phase 2)Study completedNCT03861702
What this trial is testing

Liposomal Irinotecan in Combination With Oxaliplatin, Leucovorin, and 5-fluorouracil for Patients With Locally Advanced Pancreatic Carcinoma:

Who this might be right for
Locally Advanced Pancreatic Carcinoma(LAPC)
Nelson Yee 28
Testing effectiveness (Phase 2)Ended earlyNCT00089102
What this trial is testing

Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Medical University of South Carolina 9
Testing effectiveness (Phase 2)UnknownNCT03963193
What this trial is testing

Etoposide/Cisplatin Compared With Irinotecan/Cisplatin for Advanced Gastrointestinal Neuroendocrine Tumor G3 Type

Who this might be right for
Gastrointestinal Neuroendocrine Tumor
Henan Cancer Hospital 112
Testing effectiveness (Phase 2)Study completedNCT00532714
What this trial is testing

Phase II Study of Irinotecan/Capecitabine in Patients With Antracycline/Taxane Pretreated MBC

Who this might be right for
Breast Cancer Metastatic
National Cancer Center, Korea 36
Testing effectiveness (Phase 2)Temporarily pausedNCT00209664
What this trial is testing

Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Hokkaido Gastrointestinal Cancer Study Group 40
Early research (Phase 1)Looking for participantsNCT06867822
What this trial is testing

Trial of ProAgio in Advanced/Metastatic Colorectal Cancer

Who this might be right for
Advanced Colorectal CancerMetastatic Colorectal Cancer
University of Alabama at Birmingham 27
Next Page